Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.
Cancers (Basel)
June 2025
Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
: Immune-related cutaneous adverse events (ircAEs) are common complications of cancer immunotherapy and provide insight into immune-related adverse events (irAEs) more broadly. To enhance our molecular understanding, we characterized ircAEs resulting from single-agent (PD1) and combined immunotherapy regimens (P+C). Clinically, maculopapular rash (MPR) and toxic epidermal necrolysis (TEN) resemble ircAEs, providing a valuable basis for investigations.
View Article and Find Full Text PDFChallenges Psoriasis and Its Impact on Quality of Life: Challenges in Treatment and Management.
Psoriasis (Auckl)
May 2025
Department of Nursing, Faculty of Nursing and Midwifery, Wroclaw Medical University, Wroclaw, Poland.
Psoriasis, a chronic inflammatory disease affecting approximately 3% of the global population, presents complex challenges that extend beyond its physical manifestations. This comprehensive review examines the multidimensional impact of psoriasis on patients' lives, encompassing physical, psychological, and social aspects. We analyze current therapeutic approaches, from traditional systemic treatments to cutting-edge biological therapies and emerging oral medications, evaluating their efficacy, limitations, and accessibility.
View Article and Find Full Text PDF["Biomedicines in oncodermatology"].
Rev Prat
February 2021
"Service de dermatologie, Centre d'oncodermatologie, hôpital Saint-Louis, Paris, FranceUnité 976, INSERM, Université Paris Diderot, Paris, France".
Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Br J Dermatol
June 2021
Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
Background: Primary cutaneous lymphomas (PCLs) are a heterogeneous group of T-cell (CTCL) and B-cell (CBCL) malignancies. Little is known about their epidemiology at initial presentation in Europe and about potential changes over time.
Objectives: The aim of this retrospective study was to analyse the frequency of PCLs in the French Cutaneous Lymphoma Registry (GFELC) and to describe the demography of patients.
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
J Transl Med
July 2016
McGill University, MUHC Royal Victoria Hospital, Montreal, QC Canada
MELANOMA BRIDGE 2015 KEYNOTE SPEAKER PRESENTATIONS Molecular and immuno-advances K1 Immunologic and metabolic consequences of PI3K/AKT/mTOR activation in melanoma Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A.
View Article and Find Full Text PDF